Target intelligence / Profile preview

Influenza A virus hemagglutinin (HA) sialic acid receptor-binding site (HA RBS)

Target
HA RBS
Molecular classification
Viral surface glycoprotein, Lectin, Class I viral fusion protein
01

Overview

The Influenza A virus hemagglutinin (HA) sialic acid receptor-binding site (RBS) is a critical functional domain located on the distal globular head of the HA surface glycoprotein [4, 12]. Its primary biological role is to mediate the initial attachment of the virus to host cells by binding to terminal sialic acid residues on cell-surface glycoproteins and glycolipids, a process that initiates the viral entry cycle [7, 17]. The RBS is composed of several conserved structural elements, including the 130-loop, 150-loop, 190-helix, and 220-loop, which coordinate to define the site's affinity and specificity for different sialic acid linkages [4, 12]. This specificity is a key determinant of host tropism, distinguishing between avian-like (alpha-2,3) and human-like (alpha-2,6) receptors, and is thus a major factor in pandemic potential [13, 23]. In the context of disease, the RBS is the primary target for the host's neutralizing antibody response; however, the virus frequently undergoes antigenic drift through mutations in and around the RBS to evade this immunity [12, 18]. Therapeutically, the RBS is a major focus for the development of universal vaccines and entry inhibitors [1, 10]. While most seasonal vaccines elicit strain-specific antibodies, research into broadly neutralizing antibodies (bnAbs) like C05 and CH65, as well as small-molecule mimics and peptides like the EB peptide, aims to target the conserved core of the RBS to provide protection against a wide range of influenza subtypes [6, 10, 20]. Challenges in targeting this site include glycan shielding and the need to maintain a functional balance between HA binding and neuraminidase cleavage for efficient viral fitness [5, 11, 19].

Other names
Hemagglutinin receptor-binding siteHA receptor-binding pocketSialic acid-binding siteHA1 receptor-binding domainInfluenza A virus HA RBSHA RBS
02

Mechanism of action

Inhibition of viral attachment to host cell sialic acid receptors, thereby preventing viral entry and subsequent replication.

03

Biological functions

Viral attachmentViral entryHost tropism determinationReceptor binding
04

Disease associations

InfectionInfluenza ARespiratory disease
05

Safety considerations

Antigenic driftStrain specificityGlycan shieldingAntibody-dependent enhancement (ADE)HA-NA functional balance disruption
06

Interacting drugs

MHAA4549A

10 more in the full profile.

07

Biomarkers

Hemagglutination inhibition (HI) titerHA-specific antibody levelsViral loadSialic acid linkage preference (alpha-2,3 vs alpha-2,6)

Beyond the preview

Go deeper on Influenza A virus hemagglutinin (HA) sialic acid receptor-binding site (HA RBS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin (HA) sialic acid receptor-binding site (HA RBS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call